Zimmer Biomet Holdings, Inc (NYSE:ZBH) announced plans to phase out its CPT Hip System by December. The decision comes on the ...

Individuals with limited mobility due to hip, knee, shoulder or other joint pain, can share their stories as part of the joint campaign. GlobalData analysis places Zimmer Biomet as one of the leading ...

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that it is highlighting its diverse portfolio of orthopedic and musculoskeletal innovations at the ...

We came across a bullish thesis on Zimmer Biomet Holdings, Inc. (ZBH) on Twitter by QuestforYield. In this article, we will ...

we expect our S.E.T. business to be larger than our Hip business, and to grow at a much faster pace," said Ivan Tornos, Zimmer Biomet's President and CEO. Operating margin improved to 19.2% from ...

President and Chief Executive Officer at Zimmer Biomet. "We are in the midst of one of the largest innovation cycles in our company's history. Our broad hip reconstruction portfolio combined with ...

Zimmer Biomet posted Q4 adjusted EPS of $2.31, surpassing estimates, with sales of $2.02B, driven by strong knee and hip product growth. The company expects FY25 adjusted EPS of $8.15-$8.35 ...